{"id":10998,"date":"2026-03-01T01:01:41","date_gmt":"2026-03-01T01:01:41","guid":{"rendered":"https:\/\/pharmamachinecn.com\/?p=10998"},"modified":"2026-03-12T02:16:07","modified_gmt":"2026-03-12T02:16:07","slug":"data-integrity-in-the-pharmaceutical-industry","status":"publish","type":"post","link":"https:\/\/pharmamachinecn.com\/tr\/data-integrity-in-the-pharmaceutical-industry\/","title":{"rendered":"\u0130la\u00e7 End\u00fcstrisinde Veri B\u00fct\u00fcnl\u00fc\u011f\u00fc"},"content":{"rendered":"<div data-elementor-type=\"wp-post\" data-elementor-id=\"10998\" class=\"elementor elementor-10998\" data-elementor-post-type=\"post\">\n\t\t\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-656075b4 elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"656075b4\" data-element_type=\"section\" data-e-type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-78348194\" data-id=\"78348194\" data-element_type=\"column\" data-e-type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-2b902b66 product-data-tab elementor-widget elementor-widget-text-editor\" data-id=\"2b902b66\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p>\u0130la\u00e7 \u00fcretiminin her a\u015famas\u0131 do\u011fru ve g\u00fcvenilir verilere ba\u011fl\u0131d\u0131r. K\u00fc\u00e7\u00fck bir hata bile \u00fcr\u00fcn g\u00fcvenli\u011fini ve hasta sa\u011fl\u0131\u011f\u0131n\u0131 etkileyebilir, bu nedenle bilgilerin korunmas\u0131 \u00e7ok \u00f6nemlidir. \u0130la\u00e7 end\u00fcstrisinde veri b\u00fct\u00fcnl\u00fc\u011f\u00fc, d\u00fcr\u00fcst kay\u0131tlar\u0131n tutulmas\u0131na ve g\u00fcvenli \u00fcretimin desteklenmesine yard\u0131mc\u0131 olur. Bu makalede, veri b\u00fct\u00fcnl\u00fc\u011f\u00fcn\u00fcn rol\u00fcn\u00fc ve \u00f6nemini ele alaca\u011f\u0131z.<\/p><figure id=\"attachment_11000\" aria-describedby=\"caption-attachment-11000\" style=\"width: 1000px\" class=\"wp-caption aligncenter\"><img fetchpriority=\"high\" decoding=\"async\" class=\"size-full wp-image-11000\" src=\"https:\/\/pharmamachinecn.com\/wp-content\/uploads\/2026\/03\/Data-Integrity-in-the-Pharmaceutical-Industry.jpg\" alt=\"\u0130la\u00e7 End\u00fcstrisinde Veri B\u00fct\u00fcnl\u00fc\u011f\u00fc\" width=\"1000\" height=\"652\" srcset=\"https:\/\/pharmamachinecn.com\/wp-content\/uploads\/2026\/03\/Data-Integrity-in-the-Pharmaceutical-Industry.jpg 1000w, https:\/\/pharmamachinecn.com\/wp-content\/uploads\/2026\/03\/Data-Integrity-in-the-Pharmaceutical-Industry-300x196.jpg 300w, https:\/\/pharmamachinecn.com\/wp-content\/uploads\/2026\/03\/Data-Integrity-in-the-Pharmaceutical-Industry-768x501.jpg 768w, https:\/\/pharmamachinecn.com\/wp-content\/uploads\/2026\/03\/Data-Integrity-in-the-Pharmaceutical-Industry-18x12.jpg 18w, https:\/\/pharmamachinecn.com\/wp-content\/uploads\/2026\/03\/Data-Integrity-in-the-Pharmaceutical-Industry-600x391.jpg 600w\" sizes=\"(max-width: 1000px) 100vw, 1000px\" \/><figcaption id=\"caption-attachment-11000\" class=\"wp-caption-text\"><em><strong>\u0130la\u00e7 End\u00fcstrisinde Veri B\u00fct\u00fcnl\u00fc\u011f\u00fc.<\/strong><\/em><\/figcaption><\/figure><h2><strong>\u0130la\u00e7 End\u00fcstrisinde Veri B\u00fct\u00fcnl\u00fc\u011f\u00fc Nedir?<\/strong><\/h2><p>\u0130la\u00e7 end\u00fcstrisinde veri b\u00fct\u00fcnl\u00fc\u011f\u00fc, t\u00fcm verilerin olu\u015fturuldu\u011fu andan itibaren eksiksiz, do\u011fru ve de\u011fi\u015ftirilmemi\u015f olarak saklanmas\u0131 anlam\u0131na gelir. Bu, ila\u00e7lar\u0131n ara\u015ft\u0131r\u0131lmas\u0131, \u00fcretimi ve test edilmesi s\u0131ras\u0131nda olu\u015fturulan her kayd\u0131 kapsar. Buna ka\u011f\u0131t belgeler, elektronik dosyalar, laboratuvar sonu\u00e7lar\u0131 ve makine okumalar\u0131 dahildir.<br \/><iframe title=\"\u0130la\u00e7 Sekt\u00f6r\u00fcnde Veri B\u00fct\u00fcnl\u00fc\u011f\u00fc \u2013 Fark\u0131ndal\u0131k Anahtar Niteli\u011finde\" src=\"https:\/\/www.youtube.com\/embed\/NfIWk6xA40A\" width=\"676\" height=\"391\" frameborder=\"0\" allowfullscreen=\"allowfullscreen\"><\/iframe><\/p><p><strong>Video kayna\u011f\u0131:<\/strong> <a href=\"https:\/\/www.youtube.com\/watch?v=NfIWk6xA40A\" target=\"_blank\" rel=\"noopener\"><span style=\"text-decoration: underline;\">https:\/\/www.youtube.com\/watch?v=NfIWk6xA40A<\/span><\/a><\/p><p>\u00d6rne\u011fin, yeni bir ila\u00e7 \u00fcretilirken, \u00fcretim s\u0131ras\u0131nda makineler taraf\u0131ndan kaydedilen s\u0131cakl\u0131k ve bas\u0131n\u00e7 verilerinin do\u011fru ve g\u00fcvenli bir \u015fekilde saklanmas\u0131 gerekir. <a href=\"https:\/\/pharmamachinecn.com\/tr\/machine-operation-training\/\"><u>\u015eantiyede makine e\u011fitimi<\/u><\/a>\u00a0\u00c7al\u0131\u015fanlar\u0131n bu t\u00fcr verileri do\u011fru bir \u015fekilde kaydetmeyi ve i\u015flemeyi \u00f6\u011frenmelerine yard\u0131mc\u0131 olur.<\/p><p>Veri b\u00fct\u00fcnl\u00fc\u011f\u00fc, her bir kayd\u0131n onu olu\u015fturan ki\u015fiye ve olu\u015fturulma zaman\u0131na kadar izlenebilmesi anlam\u0131na da gelir. Bilgi ister yaz\u0131l\u0131 ister elektronik olsun, anla\u015f\u0131l\u0131r, \u00f6zg\u00fcn ve ihtiya\u00e7 duyuldu\u011funda kolayca okunabilir olmal\u0131d\u0131r. <a href=\"https:\/\/www.sciencedirect.com\/science\/article\/pii\/S2949866X24001060\" target=\"_blank\" rel=\"noopener\"><u>veri b\u00fct\u00fcnl\u00fc\u011f\u00fc i\u00e7in uygulamalar ve stratejiler<\/u><\/a>\u00a0Bu kurallara uyuldu\u011fu takdirde, \u015firketler verilerinin eksiksiz ve g\u00fcvenilir kalmas\u0131n\u0131 sa\u011flayabilirler.<\/p><h2><strong>\u0130la\u00e7 Sekt\u00f6r\u00fcnde Veri B\u00fct\u00fcnl\u00fc\u011f\u00fcn\u00fcn \u00d6nemi <\/strong><\/h2><p>Veri b\u00fct\u00fcnl\u00fc\u011f\u00fc, ila\u00e7lar\u0131n geli\u015ftirilmesi, test edilmesi ve \u00fcretilmesinde merkezi bir \u00f6neme sahiptir. Do\u011fru ve eksiksiz veri olmadan, bir ila\u00e7 \u015firketindeki hi\u00e7bir s\u00fcre\u00e7 g\u00fcvenilir veya g\u00fcvenli bir \u015fekilde tekrarlanabilir olamaz. <a href=\"https:\/\/www.researchgate.net\/publication\/334131228_Importance_of_data_integrity_its_regulation_in_pharmaceutical_industry\" target=\"_blank\" rel=\"noopener\"><u>Veri b\u00fct\u00fcnl\u00fc\u011f\u00fcn\u00fcn \u00f6nemi<\/u><\/a>\u00a0Bu durumun \u00f6nemi ne kadar vurgulansa azd\u0131r, \u00e7\u00fcnk\u00fc hasta sa\u011fl\u0131\u011f\u0131ndan \u015firket itibar\u0131na kadar her \u015feyi etkiler:<\/p><h3><strong>Hasta G\u00fcvenli\u011finin Korunmas\u0131<\/strong><\/h3><p>\u0130la\u00e7 end\u00fcstrisinde veri b\u00fct\u00fcnl\u00fc\u011f\u00fc, t\u00fcm test ve \u00fcretim verilerinin do\u011fru olmas\u0131n\u0131 sa\u011flayarak hastalar\u0131n g\u00fcvenli\u011fini korumaya yard\u0131mc\u0131 olur. Veriler do\u011fru bir \u015fekilde kaydedildi\u011finde ve takip edildi\u011finde, bu durum hastalar\u0131n korunmas\u0131n\u0131 sa\u011flar. <a href=\"https:\/\/pharmamachinecn.com\/tr\/sop-in-pharmaceutical-industry\/\"><u>\u0130la\u00e7 end\u00fcstrisindeki standart i\u015fletim prosed\u00fcrleri (SOP).<\/u><\/a>, Bu sayede g\u00fcvenli olmayan \u00fcr\u00fcnler erken a\u015famada tespit edilebilir. Bu da zararl\u0131 ila\u00e7lar\u0131n insanlara ula\u015fmas\u0131n\u0131 \u00f6nler.<\/p><h3><strong>\u00dcr\u00fcn Kalitesinin Korunmas\u0131<\/strong><\/h3><p>Sa\u011flam ve do\u011fru veriler, her partide \u00fcr\u00fcn kalitesinin ayn\u0131 kalmas\u0131n\u0131 sa\u011flar. Do\u011fru kay\u0131tlar, \u00e7al\u0131\u015fanlar\u0131n kar\u0131\u015ft\u0131rma, test etme veya paketleme s\u0131ras\u0131nda hatalar\u0131 tespit etmelerine yard\u0131mc\u0131 olur. Hassas kay\u0131t tutma i\u015flemi, her ilac\u0131n ayn\u0131 g\u00fcvenlik ve etkinlik standard\u0131n\u0131 kar\u015f\u0131lamas\u0131n\u0131 sa\u011flar.<\/p><h3><strong>Mevzuat Gerekliliklerini Kar\u015f\u0131lamak<\/strong><\/h3><p>Devlet kurumlar\u0131, herhangi bir ilac\u0131 onaylamadan \u00f6nce temiz ve eksiksiz kay\u0131tlara ihtiya\u00e7 duyar. Verilerin do\u011fru ve kolay takip edilebilir olmas\u0131, \u015firketin do\u011fru kurallara uydu\u011funu g\u00f6sterir. Bu, denetimlerden sorunsuz ge\u00e7meye ve \u015firketin \u00fcr\u00fcnlerini \u00fcretip satmas\u0131na olanak tan\u0131r.<\/p><h3><strong>G\u00fcven ve \u015eeffafl\u0131k \u0130n\u015fa Etmek<\/strong><\/h3><p>\u0130la\u00e7 end\u00fcstrisindeki veri b\u00fct\u00fcnl\u00fc\u011f\u00fc, \u015firketler, d\u00fczenleyici kurumlar ve hastalar aras\u0131nda d\u00fcr\u00fcstl\u00fc\u011f\u00fcn sa\u011flanmas\u0131na yard\u0131mc\u0131 olur. T\u00fcm sonu\u00e7lar a\u00e7\u0131k\u00e7a kaydedildi\u011finde, herkes ila\u00e7lar\u0131n nas\u0131l \u00fcretildi\u011fini kontrol edebilir. A\u00e7\u0131k s\u00fcre\u00e7 g\u00fcven olu\u015fturur ve \u015firketin itibar\u0131n\u0131 g\u00fc\u00e7lendirir.<\/p><h3><strong>Finansal ve Hukuki Risklerin Azalt\u0131lmas\u0131<\/strong><\/h3><p>Do\u011fru ve d\u00fcr\u00fcst veriler, \u015firketlerin b\u00fcy\u00fck kay\u0131plardan, \u00fcr\u00fcn geri \u00e7a\u011f\u0131rmalar\u0131ndan ve yasal i\u015flemlerden ka\u00e7\u0131nmas\u0131na yard\u0131mc\u0131 olur. T\u00fcm ad\u0131mlar\u0131n a\u00e7\u0131k\u00e7a kaydedilmesiyle, hatalar\u0131n tespit edilmesi ve d\u00fczeltilmesi daha kolay olur. Bu, zamandan ve paradan tasarruf sa\u011flar ve \u015firketi a\u011f\u0131r cezalardan veya itibar kayb\u0131ndan korur.<\/p><h3><strong>Denetim ve Tefti\u015fleri Destekleme<\/strong><\/h3><p>D\u00fczenli ve do\u011fru veriler, \u015firket faaliyetlerine dair net bir tablo sunarak denetimlerin daha iyi yap\u0131lmas\u0131n\u0131 destekler. Denet\u00e7iler, ila\u00e7lar\u0131n nas\u0131l \u00fcretildi\u011fini ve test edildi\u011fini kolayca takip edebilir, b\u00f6ylece gecikmeler veya \u015f\u00fcpheler azal\u0131r. Ayr\u0131ca, \u015firketin d\u00fcr\u00fcst \u00e7al\u0131\u015fma ve g\u00fcvenli \u00fcretim uygulamalar\u0131na olan ba\u011fl\u0131l\u0131\u011f\u0131n\u0131 da yans\u0131t\u0131r.<\/p><h2><strong>D\u00fczenleyici \u00c7er\u00e7eve ve K\u00fcresel Y\u00f6nergeler<\/strong><\/h2><p>\u0130la\u00e7 end\u00fcstrisindeki veri b\u00fct\u00fcnl\u00fc\u011f\u00fcne ili\u015fkin kurallar ve y\u00f6nergeler, ila\u00e7 \u00fcretiminin g\u00fcvenli ve orijinal olmas\u0131n\u0131 sa\u011flamak amac\u0131yla olu\u015fturulmu\u015ftur. Bu kurallar, \u015firketlere verilerin her a\u015famada nas\u0131l kaydedilece\u011fi, saklanaca\u011f\u0131 ve kontrol edilece\u011fi konusunda yol g\u00f6sterir. Bu k\u00fcresel kurallar, t\u00fcm \u00fclkelerin ayn\u0131 standartlar\u0131 izlemesine ve d\u00fcnyan\u0131n her yerinde hastalar\u0131n korunmas\u0131na yard\u0131mc\u0131 olur.<\/p><h3><strong>D\u00fczenleyici \u00c7er\u00e7eve ve K\u00fcresel Y\u00f6nergeler<\/strong><\/h3><p>Uluslararas\u0131 kurulu\u015flar, ila\u00e7 \u015firketlerinin g\u00fcvenli uygulamalar\u0131 takip etmelerini sa\u011flamak i\u00e7in net kurallar belirlemi\u015ftir.<\/p><p>Kurallar, verilerin nas\u0131l olu\u015fturuldu\u011funu, i\u015flendi\u011fini ve kaydedildi\u011fini kapsar. <a href=\"https:\/\/pharmamachinecn.com\/tr\/pharmaceutical-production-line\/\"><u>ila\u00e7 \u00fcretim hatt\u0131<\/u><\/a>. Ayr\u0131ca, test malzemelerinden nihai ilac\u0131n ambalaj\u0131na kadar t\u00fcm bilgilerin eksiksiz ve de\u011fi\u015ftirilmemi\u015f kalmas\u0131n\u0131 \u015fart ko\u015fuyorlar.<\/p><h3><strong>Avrupa Birli\u011fi GMP Ek 11 ve Ek 15<\/strong><\/h3><p>Avrupa Birli\u011fi, Ek 11 arac\u0131l\u0131\u011f\u0131yla ayr\u0131nt\u0131l\u0131 talimatlar vermektedir ve <a href=\"https:\/\/health.ec.europa.eu\/document\/download\/7c6c5b3c-4902-46ea-b7ab-7608682fb68d_en?filename=2015-10_annex15.pdf\" target=\"_blank\" rel=\"noopener\"><u>Ek 15<\/u><\/a>\u00a0\u0130yi \u00dcretim Uygulamalar\u0131 (GMP) standartlar\u0131na g\u00f6re, Ek 11 verilerin g\u00fcvenli\u011fini sa\u011flamak i\u00e7in bilgisayar ve elektronik sistemlere odaklan\u0131rken, Ek 15 ekipman\u0131n nas\u0131l test edilece\u011fini ve nitelendirilece\u011fini a\u00e7\u0131klamaktad\u0131r.<\/p><p>Birlikte, dijital ve fiziksel kay\u0131tlar\u0131n do\u011fru ve izlenebilir kalmas\u0131n\u0131 sa\u011flayarak ila\u00e7 end\u00fcstrisinde veri b\u00fct\u00fcnl\u00fc\u011f\u00fcn\u00fc yerine getiriyorlar.<\/p><h3><strong>DS\u00d6 ve PIC\/S Rehber Belgeleri<\/strong><\/h3><p>The <a href=\"https:\/\/www.who.int\/\" target=\"_blank\" rel=\"noopener\"><span style=\"text-decoration: underline;\">D\u00fcnya Sa\u011fl\u0131k \u00d6rg\u00fct\u00fc<\/span><\/a> (DS\u00d6) ile <a href=\"https:\/\/picscheme.org\/\" target=\"_blank\" rel=\"noopener\"><span style=\"text-decoration: underline;\">\u0130la\u00e7 Denetimi \u0130\u015fbirli\u011fi Program\u0131<\/span><\/a> (PIC\/S), bir\u00e7ok \u00fclke taraf\u0131ndan kullan\u0131lan k\u0131lavuzlar sunmaktad\u0131r. \u015eirketlerin d\u00fcr\u00fcstl\u00fck ve do\u011fru kay\u0131t tutma konusunda g\u00fc\u00e7l\u00fc bir k\u00fclt\u00fcr olu\u015fturmalar\u0131na yard\u0131mc\u0131 olurlar. Bu belgeler ayr\u0131ca denetimlerin nas\u0131l yap\u0131lmas\u0131 gerekti\u011fini ve personelin verileri nas\u0131l sorumlu bir \u015fekilde ele almas\u0131 gerekti\u011fini de a\u00e7\u0131klamaktad\u0131r.<\/p><h2><strong>S\u0131k Kar\u015f\u0131la\u015f\u0131lan Veri B\u00fct\u00fcnl\u00fc\u011f\u00fc Sorunlar\u0131<\/strong><\/h2><p>\u0130la\u00e7 geli\u015ftirme ve test s\u00fcre\u00e7lerinde verilerin i\u015flenmesini etkileyebilecek bir\u00e7ok sorun vard\u0131r. Bunlar \u015funlard\u0131r: <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/36529357\/\" target=\"_blank\" rel=\"noopener\"><u>\u0130la\u00e7 end\u00fcstrisindeki veri b\u00fct\u00fcnl\u00fc\u011f\u00fc sorunlar\u0131<\/u><\/a>\u00a0Bu durumlar\u0131n \u00e7o\u011fu insan hatas\u0131 veya yetersiz kay\u0131t tutma nedeniyle meydana gelir. Verilerin do\u011fru ve eksiksiz kalmas\u0131 i\u00e7in bu hatalar\u0131 erken tespit edip d\u00fczeltmek \u00f6nemlidir.<\/p><h3><strong>\u0130nsan Hatalar\u0131 ve Yetersiz Dok\u00fcmantasyon<\/strong><\/h3><p>Test sonu\u00e7lar\u0131n\u0131 kaydetmeyi unutmak veya sonradan yazmak gibi basit hatalar b\u00fcy\u00fck sorunlara yol a\u00e7abilir. Eksik veya belirsiz bilgiler, bir s\u00fcrecin do\u011fru yap\u0131ld\u0131\u011f\u0131n\u0131 kan\u0131tlamay\u0131 zorla\u015ft\u0131r\u0131r. Dikkatli e\u011fitim ve ger\u00e7ek zamanl\u0131 kay\u0131t, bu t\u00fcr hatalar\u0131 azaltmaya yard\u0131mc\u0131 olur.<\/p><h3><strong>Veri Manip\u00fclasyonu<\/strong><\/h3><p>Sonu\u00e7lar\u0131 daha iyi g\u00f6stermek i\u00e7in verileri de\u011fi\u015ftirmek, gizlemek veya yeniden girmek ciddi bir sorundur. G\u00fcveni zedeler ve g\u00fcvenli olmayan ila\u00e7lar\u0131n piyasaya s\u00fcr\u00fclmesine yol a\u00e7abilir. \u015eirketler, bu t\u00fcr davran\u0131\u015flar\u0131 durdurmak ve ila\u00e7 end\u00fcstrisinde veri b\u00fct\u00fcnl\u00fc\u011f\u00fcn\u00fc korumak i\u00e7in kay\u0131tlar\u0131 kontrol etmelidir.<\/p><h3><strong>Eksik veya Kay\u0131p Kay\u0131tlar<\/strong><\/h3><p>Bazen, k\u00f6t\u00fc depolama veya bilgisayar ar\u0131zalar\u0131 nedeniyle \u00f6nemli dosyalar veya raporlar kaybolabilir. Bu durum, bir \u00fcr\u00fcn\u00fcn nas\u0131l \u00fcretildi\u011fini veya test edildi\u011fini do\u011frulamay\u0131 imkans\u0131z hale getirir. G\u00fcvenli yedeklemeler ve d\u00fczenli sistemler bu sorunu \u00f6nlemeye yard\u0131mc\u0131 olur.<\/p><h2><strong>\u0130la\u00e7 Veri B\u00fct\u00fcnl\u00fc\u011f\u00fcn\u00fcn Prensipleri <\/strong><\/h2><p>\u0130la\u00e7 end\u00fcstrisinde verilerin g\u00fcvenli ve do\u011fru tutulmas\u0131n\u0131n temel kurallar\u0131na veri b\u00fct\u00fcnl\u00fc\u011f\u00fc ilkeleri denir. Bu ilkeler, t\u0131bbi ara\u015ft\u0131rma, test ve \u00fcretim s\u0131ras\u0131nda toplanan her bilginin do\u011fru ve eksiksiz olmas\u0131n\u0131 sa\u011flar. G\u00fcnl\u00fck \u00e7al\u0131\u015fmalarda kay\u0131tlar\u0131n nas\u0131l olu\u015fturulmas\u0131, kontrol edilmesi ve saklanmas\u0131 gerekti\u011fine dair yol g\u00f6sterirler.<\/p><p><strong>Temel Prensipler:<\/strong><\/p><ul><li><strong>Atfedilebilir: <\/strong>Her bir kay\u0131tta i\u015fi kimin yapt\u0131\u011f\u0131 ve ne zaman tamamland\u0131\u011f\u0131 belirtilmelidir.<\/li><li><strong>Okunabilir:<\/strong>T\u00fcm kay\u0131tlar anla\u015f\u0131l\u0131r ve her zaman kolayca okunabilir olmal\u0131d\u0131r.<\/li><li><strong>E\u015fzamanl\u0131: <\/strong>Veriler, i\u015flem yap\u0131l\u0131rken ayn\u0131 anda yaz\u0131lmal\u0131 veya kaydedilmelidir.<\/li><li><strong>Orijinal: <\/strong>\u0130lk kay\u0131t veya onayl\u0131 bir kopyas\u0131 her zaman g\u00fcvenli bir \u015fekilde saklanmal\u0131d\u0131r.<\/li><li><strong>Kesin: <\/strong>T\u00fcm bilgilerin do\u011fru ve hatas\u0131z olmas\u0131 gerekmektedir.<\/li><li><strong>Tamamlamak: <\/strong>S\u00fcrecin her a\u015famas\u0131, hi\u00e7bir \u015fey atlanmadan kay\u0131t alt\u0131na al\u0131nmal\u0131d\u0131r.<\/li><\/ul><p>Bu ilkeler, \u00fcretimin ba\u015flang\u0131c\u0131ndan nihai ilaca kadar bilgilerin g\u00fcvenilirli\u011fini korumak i\u00e7in birlikte \u00e7al\u0131\u015f\u0131r. Bu ilkeleri takip ederek, \u015firketler her sonucun do\u011fru oldu\u011funu, her ad\u0131m\u0131n kaydedildi\u011fini ve hi\u00e7bir \u015feyin gizlenmedi\u011fini veya de\u011fi\u015ftirilmedi\u011fini kan\u0131tlayabilir. Bu da hastalar i\u00e7in \u00fcretilen ila\u00e7lar\u0131n g\u00fcvenli\u011fi ve kalitesine olan g\u00fcveni art\u0131r\u0131r.<\/p><h2><strong>SSS<\/strong><\/h2><h3><strong>Veri b\u00fct\u00fcnl\u00fc\u011f\u00fcn\u00fcn d\u00f6rt t\u00fcr\u00fc nelerdir?<\/strong><\/h3><p>Veri b\u00fct\u00fcnl\u00fc\u011f\u00fcn\u00fcn d\u00f6rt t\u00fcr\u00fc vard\u0131r: fiziksel, mant\u0131ksal, varl\u0131k ve referans b\u00fct\u00fcnl\u00fc\u011f\u00fc. Fiziksel b\u00fct\u00fcnl\u00fck verileri hasardan korurken, mant\u0131ksal b\u00fct\u00fcnl\u00fck bilgilerin do\u011fru kalmas\u0131n\u0131 sa\u011flar. Varl\u0131k ve referans b\u00fct\u00fcnl\u00fc\u011f\u00fc ise verilerin veritabanlar\u0131 i\u00e7inde tutarl\u0131 ve do\u011fru \u015fekilde ba\u011flant\u0131l\u0131 kalmas\u0131n\u0131 sa\u011flar.<\/p><h3><strong>\u0130la\u00e7 sekt\u00f6r\u00fcnde Alcoa+++ nedir?<\/strong><\/h3><p><a href=\"https:\/\/www.linkedin.com\/posts\/um-e-habiba-quality-control-analyst-b04ab8180_alcoa-the-foundation-of-data-integrity-activity-7384991988095377411-05yc#:~:text=%E2%9C%85%20L%20%E2%80%93%20Legible:%20Clear%2C,because%20quality%20begins%20with%20integrity.\" target=\"_blank\" rel=\"noopener\"><span style=\"text-decoration: underline;\">ALCOA+++ standartlar\u0131n\u0131 kar\u015f\u0131l\u0131yor<\/span><\/a> &quot;\u0130li\u015fkilendirilebilir, Okunabilir, E\u015fzamanl\u0131, Orijinal, Do\u011fru, Eksiksiz, Tutarl\u0131, Kal\u0131c\u0131 ve Eri\u015filebilir&quot; anlam\u0131na gelir. Bu, ila\u00e7 end\u00fcstrisinde t\u00fcm verilerin g\u00fcvenilir ve do\u011fru \u015fekilde kaydedilmesini sa\u011flayan bir k\u0131lavuzdur.<\/p><h3><strong>\u0130la\u00e7 sekt\u00f6r\u00fcnde verilerin do\u011frulu\u011funu nas\u0131l sa\u011fl\u0131yorsunuz?<\/strong><\/h3><p>\u0130la\u00e7 sekt\u00f6r\u00fcnde veri do\u011frulama, bilgilerin do\u011fru, eksiksiz ve g\u00fcvenilir oldu\u011funun kontrol edilmesi anlam\u0131na gelir. Bu s\u00fcre\u00e7, sistem denetimlerini, ham verilerin incelenmesini ve elektronik giri\u015flerin do\u011frulanmas\u0131n\u0131 i\u00e7erir.<\/p><h2><strong>\u00c7\u00f6z\u00fcm <\/strong><\/h2><p>Verilerin do\u011fru ve eksiksiz tutulmas\u0131, ila\u00e7 \u00fcretiminin \u00f6nemli bir par\u00e7as\u0131d\u0131r. Hastalar\u0131 korumaya, \u00fcr\u00fcn kalitesini s\u00fcrd\u00fcrmeye ve k\u00fcresel standartlara uymaya yard\u0131mc\u0131 olur. \u0130yi veri uygulamalar\u0131 ayr\u0131ca g\u00fcven olu\u015fturur ve s\u00fcrecin her a\u015famas\u0131nda sorumluluk g\u00f6sterir.<\/p><p>Ambalaj ekipman\u0131na y\u00f6nelik makinelere ihtiyac\u0131n\u0131z varsa, \u00e7ok \u00e7e\u015fitli se\u00e7enekler sunuyoruz. Koleksiyonumuzda kaps\u00fcl \u015ferit ambalaj makineleri ve di\u011fer bir\u00e7ok ila\u00e7 makinesi t\u00fcr\u00fc bulunmaktad\u0131r. Ayr\u0131ca \u00fcretim ihtiya\u00e7lar\u0131n\u0131z\u0131 desteklemek i\u00e7in istedi\u011finiz zaman talep edebilece\u011finiz hizmetler de sunuyoruz. <a href=\"https:\/\/pharmamachinecn.com\/tr\/contact-us\/\"><u>Bug\u00fcn bizimle ileti\u015fime ge\u00e7in.<\/u><\/a>\u00a0Makine ve hizmetlerimiz hakk\u0131nda bilgi i\u00e7in.<\/p><h2><strong>Referanslar:<\/strong><\/h2><p><a href=\"https:\/\/www.eurofins.com\/assurance\/resources\/articles\/what-is-data-integrity-in-pharma-and-what-are-the-five-principles\/\" target=\"_blank\" rel=\"noopener\"><span style=\"text-decoration: underline;\"><em><strong>\u0130la\u00e7ta veri b\u00fct\u00fcnl\u00fc\u011f\u00fc nedir ve be\u015f ilke nelerdir?<\/strong><\/em><\/span><\/a><\/p><p><a href=\"https:\/\/www.sciencedirect.com\/science\/article\/abs\/pii\/S0003450925001476\" target=\"_blank\" rel=\"noopener\"><span style=\"text-decoration: underline;\"><em><strong>Farmas\u00f6tik ya\u015fam d\u00f6ng\u00fcs\u00fcnde veri b\u00fct\u00fcnl\u00fc\u011f\u00fcn\u00fcn sa\u011flanmas\u0131: Zorluklar, ilkeler ve k\u00fcresel \u00e7\u0131kar\u0131mlar<\/strong><\/em><\/span><\/a>.<\/p><p><a href=\"https:\/\/www.suanfarma.com\/quality\/data-integrity-in-the-pharmaceutical-industry\/\" target=\"_blank\" rel=\"noopener\"><span style=\"text-decoration: underline;\"><em><strong>\u0130la\u00e7 End\u00fcstrisinde Veri B\u00fct\u00fcnl\u00fc\u011f\u00fc<\/strong><\/em><\/span><\/a>.<\/p><p><a href=\"https:\/\/www.vimachem.com\/resources\/articles\/how-to-ensure-data-integrity-in-pharmaceutical-manufacturing\/\" target=\"_blank\" rel=\"noopener\"><span style=\"text-decoration: underline;\"><em><strong>\u0130la\u00e7 \u00dcretiminde Veri B\u00fct\u00fcnl\u00fc\u011f\u00fc Nas\u0131l Sa\u011flan\u0131r?<\/strong><\/em><\/span><\/a>.<\/p><p><a href=\"https:\/\/fivevalidation.com\/data-integrity-in-the-pharmaceutical-industry\/\" target=\"_blank\" rel=\"noopener\"><span style=\"text-decoration: underline;\"><em><strong>\u0130la\u00e7 End\u00fcstrisinde Veri B\u00fct\u00fcnl\u00fc\u011f\u00fc<\/strong><\/em><\/span><\/a>.<\/p><p><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/36529357\/\" target=\"_blank\" rel=\"noopener\"><span style=\"text-decoration: underline;\"><em><strong>\u0130la\u00e7 end\u00fcstrisinde veri b\u00fct\u00fcnl\u00fc\u011f\u00fc sorunlar\u0131: Yayg\u0131n g\u00f6zlemler, zorluklar ve hafifletme stratejileri.<\/strong><\/em><\/span><\/a><\/p><h2><b>Telif Hakk\u0131 Uyar\u0131s\u0131:\u00a0<\/b><\/h2><p>Finetech Group'un \u00f6nceden a\u00e7\u0131k yaz\u0131l\u0131 onay\u0131 olmadan bu web sitesindeki herhangi bir i\u00e7eri\u011fi \u00e7o\u011faltamaz, de\u011fi\u015ftiremez, yay\u0131nlayamaz, g\u00f6r\u00fcnt\u00fcleyemez, iletemez veya herhangi bir \u015fekilde istismar edemezsiniz veya bu t\u00fcr i\u00e7eri\u011fi herhangi bir veritaban\u0131 olu\u015fturmak i\u00e7in kullanamazs\u0131n\u0131z. \u0130\u00e7eri\u011fi kullanma izni i\u00e7in l\u00fctfen ileti\u015fime ge\u00e7in: <a href=\"mailto:info@pharmamachinecn.com\"><span style=\"text-decoration: underline;\">info@pharmamachinecn.com<\/span><\/a><\/p><h2><b>Yasal Uyar\u0131:<\/b><\/h2><p>Bu makalede yer alan bilgiler yaln\u0131zca genel bilgilendirme ama\u00e7l\u0131d\u0131r. \u015eirket, herhangi bir bilginin do\u011frulu\u011funu, g\u00fcncelli\u011fini veya eksiksizli\u011fini garanti etmez ve \u015eirket, bu makalenin i\u00e7eri\u011findeki hatalar veya eksiklikler i\u00e7in hi\u00e7bir sorumluluk kabul etmez.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<\/div>","protected":false},"excerpt":{"rendered":"<p>Every stage of medicine production depends on correct and trusted data. Even a small mistake can affect product safety and [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":11000,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","ast-disable-related-posts":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"categories":[61],"tags":[],"class_list":["post-10998","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-pharmaceutical-technology"],"acf":[],"_links":{"self":[{"href":"https:\/\/pharmamachinecn.com\/tr\/wp-json\/wp\/v2\/posts\/10998","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharmamachinecn.com\/tr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharmamachinecn.com\/tr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharmamachinecn.com\/tr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/pharmamachinecn.com\/tr\/wp-json\/wp\/v2\/comments?post=10998"}],"version-history":[{"count":10,"href":"https:\/\/pharmamachinecn.com\/tr\/wp-json\/wp\/v2\/posts\/10998\/revisions"}],"predecessor-version":[{"id":13046,"href":"https:\/\/pharmamachinecn.com\/tr\/wp-json\/wp\/v2\/posts\/10998\/revisions\/13046"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/pharmamachinecn.com\/tr\/wp-json\/wp\/v2\/media\/11000"}],"wp:attachment":[{"href":"https:\/\/pharmamachinecn.com\/tr\/wp-json\/wp\/v2\/media?parent=10998"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharmamachinecn.com\/tr\/wp-json\/wp\/v2\/categories?post=10998"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharmamachinecn.com\/tr\/wp-json\/wp\/v2\/tags?post=10998"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}